|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-6-8
|
|
pubmed:abstractText |
To assess the safety, tolerability and efficacy of a new cyclosporin A (CyA) microemulsion formulation, Sandimmun Neoral (Neoral), in patients with severe psoriasis that was stable on CyA administered as Sandimmun (SIM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1018-8665
|
|
pubmed:author |
pubmed-author:AbramsBB,
pubmed-author:BleehenS SSS,
pubmed-author:BräutigamMM,
pubmed-author:BurrowsDD,
pubmed-author:EtteltM JMJ,
pubmed-author:FoàVV,
pubmed-author:GanslandtJJ,
pubmed-author:HappleRR,
pubmed-author:HausteinU FUF,
pubmed-author:JungE GEG,
pubmed-author:KühneK HKH,
pubmed-author:KnoxBB,
pubmed-author:MørkN JNJ,
pubmed-author:MelleinBB,
pubmed-author:RogersSS,
pubmed-author:SchmidtA GAG,
pubmed-author:SchopfR ERE,
pubmed-author:SumnerMM,
pubmed-author:TaubeK MKM,
pubmed-author:WeidingerGG,
pubmed-author:WurdelCC,
pubmed-author:ZachariaeHH,
pubmed-author:ZahnEE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
196
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
231-6
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9568413-Adolescent,
pubmed-meshheading:9568413-Adult,
pubmed-meshheading:9568413-Aged,
pubmed-meshheading:9568413-Breast Neoplasms,
pubmed-meshheading:9568413-Chemistry, Pharmaceutical,
pubmed-meshheading:9568413-Creatinine,
pubmed-meshheading:9568413-Cyclosporine,
pubmed-meshheading:9568413-Dose-Response Relationship, Drug,
pubmed-meshheading:9568413-Drug Evaluation,
pubmed-meshheading:9568413-Emulsions,
pubmed-meshheading:9568413-Female,
pubmed-meshheading:9568413-Humans,
pubmed-meshheading:9568413-Immunosuppressive Agents,
pubmed-meshheading:9568413-Kidney Calculi,
pubmed-meshheading:9568413-Leg,
pubmed-meshheading:9568413-Male,
pubmed-meshheading:9568413-Menorrhagia,
pubmed-meshheading:9568413-Middle Aged,
pubmed-meshheading:9568413-Pain,
pubmed-meshheading:9568413-Psoriasis,
pubmed-meshheading:9568413-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
